These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38467081)

  • 21. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD.
    Novitzky-Basso I; Patriquin C; Linn SM; Chiarello C; Pasic I; Lam W; Law A; Michelis FV; Gerbitz A; Viswabandya A; Lipton J; Kumar R; Mattsson J; Barth D; Kim DDH
    Transplant Cell Ther; 2023 Dec; 29(12):773.e1-773.e10. PubMed ID: 37797719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.
    Cogbill CH; Drobyski WR; Komorowski RA
    Mod Pathol; 2011 Jan; 24(1):117-25. PubMed ID: 20953169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Care for patients undergoing extracorporeal photopheresis to treat chronic graft-versus-host disease: review of the evidence.
    Woltz P; Castro K; Park BJ
    Clin J Oncol Nurs; 2006 Dec; 10(6):795-802. PubMed ID: 17193945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic graft-versus-host disease].
    Rørvik SD; Abrahamsen IW; Myhre AE; Vo CD; Ødegaard EM; Bruserud Ø; Gedde-Dahl T; Tvedt THA
    Tidsskr Nor Laegeforen; 2023 Mar; 143(4):. PubMed ID: 36919292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
    Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
    Kim DDH; Popradi G; Lepic K; Paulson K; Allan D; Nampoothiri RV; Lachance S; Deotare U; White J; Elemary M; Jamani K; Fraga C; Lemieux C; Novitzky-Basso I; Law AD; Kumar R; Walker I; Schultz KR;
    Curr Oncol; 2024 Mar; 31(3):1426-1444. PubMed ID: 38534941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, Histopathological Features and Differential Diagnosis of Cutaneous Graft Versus Host Disease in Allogeneic Bone Marrow Transplantation.
    Hacisalihoglu UP; Sahin D
    Sisli Etfal Hastan Tip Bul; 2021; 55(1):68-75. PubMed ID: 33935538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden.
    Schain F; Boissin C; Laczik T; Fedeli S; Remberger M; Blennow O; Dykes J; Eich T; Jones C; Mattsson J; Berlin G
    Transfus Apher Sci; 2023 Jun; 62(3):103705. PubMed ID: 36967367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response.
    Seaton ED; Szydlo RM; Kanfer E; Apperley JF; Russell-Jones R
    Blood; 2003 Aug; 102(4):1217-23. PubMed ID: 12714516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation.
    Brownback KR; Simpson SQ; Pitts LR; Polineni D; McGuirk JP; Ganguly S; Aljitawi OS; Lin TL; Singh A; Abhyankar S
    J Clin Apher; 2016 Aug; 31(4):347-52. PubMed ID: 26031713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photopheresis: clinical use so far.
    Sanford KW; Balogun RA
    J Clin Apher; 2012; 27(3):126-31. PubMed ID: 22467383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin ulcers caused by ruxolitinib in a patient with chronic cutaneous graft-versus-host disease.
    Aslan Candır B; Yiğenoğlu TN; Kızıl Çakar M; Dal MS; Altuntaş F
    J Oncol Pharm Pract; 2022 Jun; 28(4):983-985. PubMed ID: 35019785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
    Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.